SpineEx files for $17M IPO: 3 notes

SpineEx filed to raise up to $17 million in an initial public offering Sept. 18, Renaissance Capital reports.

Advertisement

Here are three things to know:

1. SpineEx develops implants for spinal fusion surgery.

2. ThinkEquity is the deal’s only bookrunner.

3. Pricing terms were not disclosed.

More articles on devices:
Medtronic, Zimmer Biomet, Smith & Nephew & more: 15 device company notes
18 spine devices received FDA 510(k) clearance in August
Medtronic joins initiative to bring more women into board seats

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.